UNSPSC 51392503: Cyclopentamine

This classification denotes an adrenergic agent with the molecular formula C9H19N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WB9Q6M8O60, chemically known as 2-cyclopentyl-n,1-dimethylethylamine but generally known as cyclopentamine, which bears US NIH Compound Identifier 7608. European Medicines Agency schedules Cyclopentamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06856MIG. The term CYCLOPENTAMINE is an International Non-Proprietary Name.

UNSPSC 51392503 Cyclopentamine is a Commodity code showing minimal recent state and local procurement activity aligned with its nominal scope. The two recent opportunities tagged under this code — a Seminole County, Florida IFB for naloxone and drug deactivation systems, and a Texas Health and Human Services Commission RFI regarding direct-to-manufacturer prescription programs — are unrelated to cyclopentamine specifically and appear to reflect miscoding in the issuing bodies' procurement systems. The naloxone procurement is a public-health supply buy, and the Texas RFI addresses pharmacy benefit program structure rather than a pharmaceutical product line. State and local procurement activity under this code does not currently reflect purchases of cyclopentamine itself, and the nominal code scope does not align with what is actually being solicited.

Geographic activity is limited to Florida and Texas based on the recent opportunities, but the mismatch between the code designation and the work being solicited suggests that any apparent concentration is an artifact of coding error rather than genuine demand signal. No representative opportunities directly address cyclopentamine procurement. Firms should verify coding accuracy with issuing bodies before pursuing opportunities tagged under this code, as the recent record suggests systematic miscoding rather than active state and local demand for the product.